About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
SOHO Brazil 2022
https://rvmais.iweventos.com.br/site/sintoma2022
Leukemia
Lymphoma
Myeloma
MDS
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
SOHO Brazil 2022 on CLL: The BTK Inhibitors That Continue to “Heat-Up” the Class
By
SOHO Brazil 2022
FEATURING
Nitin Jain
,
Phillip Scheinberg
By
SOHO Brazil 2022
FEATURING
Nitin Jain
,
Phillip Scheinberg
16 views
August 30, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
23:35
University of Colorado Division of Hematology
2024 Updates in PV/ET
Feat.
B. McMahon
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Leukemia
23:10
SOHO Brazil 2022
SOHO Brazil 2022: All You Need to Know (Until Now) About Targeted Th…
Feat.
K. Pratz,
P. Scheinberg
32:48
SOHO Brazil 2022
SOHO Brazil 2022 on Refractory ALL: What Is the Precise Time to Indi…
Feat.
M. Bishop,
P. Scheinberg
16:45
SOHO Brazil 2022
SOHO Brazil 2022 on CLL: The PI3K Inhibitors, the "Not-So-New K…
Feat.
N. Jain,
P. Scheinberg
20:09
SOHO Brazil 2022
SOHO Brazil 2022 on CLL: The BTK Inhibitors That Continue to “Heat-U…
Feat.
N. Jain,
P. Scheinberg
22:54
SOHO Brazil 2022
SOHO Brazil 2022 on Ph+ ALL: Is the Combination With TKIs Curing Pat…
Feat.
J. Ribera,
P. Scheinberg
20:04
SOHO Brazil 2022
SOHO Brazil 2022 on High-Risk AML: Is Conventional Chemo Still the B…
Feat.
D. Pollyea,
P. Scheinberg
20:23
SOHO Brazil 2022
SOHO Brazil 2022 on Doublets & Triplets With Venetoclax in AML: …
Feat.
D. Pollyea,
P. Scheinberg
26:48
SOHO Brazil 2022
SOHO Brazil 2022 on CLL: Do BTKi + BCL2 Inhibitors Need a Partner?
Feat.
N. Jain,
P. Scheinberg
25:29
SOHO Brazil 2022
SOHO Brazil 2022: Can Someone Be Destined to Develop AML? Understand…
Feat.
L. Godley,
P. Scheinberg
